Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 2,129 Jul 31 – Oct 28, 2026
- Disclosed funding
- $147.4B 1458 disclosed amounts
- Median round
- $10M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| S SouutheCompany profile Souuthe develops tactile calming products for people experiencing distress in dementia and palliative-care settings. Souuthe develops tactile calming products for people experiencing distress in dementia and palliative-care settings. | £75K | Women in Innovation grantUndisclosed | Healthtech | United Kingdom | Investors | |
| TG Triangle GroupCompany profile Builds infrastructure for live touring and festivals across Asia-Pacific Builds infrastructure for live touring and festivals across Asia-Pacific | $15M | Seed+DebtUndisclosed | Consumer | Singapore | Investors | |
 IceyeCompany profile ICEYE builds and operates radar-imaging satellites and delivers Earth-observation data and intelligence to governments and businesses. ICEYE builds and operates radar-imaging satellites and delivers Earth-observation data and intelligence to governments and businesses. | €1B | Undisclosed | Space tech | Finland | Investors | |
| ML Mitti LabsCompany profile Uses satellite imagery and AI to cut water use and methane emissions in rice farming Uses satellite imagery and AI to cut water use and methane emissions in rice farming | $9.5M | Series A | Climate tech | United States | Investors | |
| S SkinBitCompany profile Provides full-body skin scanning technology for early skin cancer detection and screening Provides full-body skin scanning technology for early skin cancer detection and screening | $6M | Pre-SeedPre-seed | Healthtech | United States | Investors | |
| M MironidCompany profile Mironid develops small-molecule medicines for inherited kidney disease, with a lead programme targeting autosomal dominant polycystic kidney disease. Mironid develops small-molecule medicines for inherited kidney disease, with a lead programme targeting autosomal dominant polycystic kidney disease. | $46M | Series B | Biotech | United Kingdom | Investors | |
 NeuraspaceCompany profile Neuraspace helps satellite operators monitor orbital traffic, assess collision risk and plan avoidance manoeuvres. Neuraspace helps satellite operators monitor orbital traffic, assess collision risk and plan avoidance manoeuvres. | €15.6M | Series B and public fundingSeries B | Space tech | Portugal | Investors | |
 VoltaCompany profile Volta develops and operates AI compute infrastructure, combining data-center sites, dedicated compute, software and operations for AI labs, AI-native companies and enterprises. Volta develops and operates AI compute infrastructure, combining data-center sites, dedicated compute, software and operations for AI labs, AI-native companies and enterprises. | $300M | Series A | AI | United Kingdom | Investors | |
| AR Avatar RoboticsCompany profile Combines humanoid robots and remote operators for warehouse and manufacturing labor Combines humanoid robots and remote operators for warehouse and manufacturing labor | $6.5M | Seed | Robotics | United States | Investors | |
| LT LifeMine TherapeuticsCompany profile Develops fungal genome-derived therapeutics for organ transplant rejection Develops fungal genome-derived therapeutics for organ transplant rejection | $263M | Series D+Series EUndisclosed | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 31, 2026
- 1Y Combinator (YC)
Vera Health, BioStack, Tractian
69rounds5led - 2Andreessen Horowitz (a16z)
Hex, ASI, Eka Robotics
47rounds18led - 3General Catalyst
Hyperbolic, Re:Build, Matiks
33rounds13led - 4Sequoia Capital
Hex, Nevis, Warhound
33rounds11led - 5Khosla Ventures
Arda Industries, Tolan
32rounds10led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →